Zahir Amoura

41.5k total citations · 3 hit papers
424 papers, 17.6k citations indexed

About

Zahir Amoura is a scholar working on Rheumatology, Immunology and Physiology. According to data from OpenAlex, Zahir Amoura has authored 424 papers receiving a total of 17.6k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Rheumatology, 122 papers in Immunology and 107 papers in Physiology. Recurrent topics in Zahir Amoura's work include Systemic Lupus Erythematosus Research (147 papers), Histiocytic Disorders and Treatments (65 papers) and T-cell and B-cell Immunology (42 papers). Zahir Amoura is often cited by papers focused on Systemic Lupus Erythematosus Research (147 papers), Histiocytic Disorders and Treatments (65 papers) and T-cell and B-cell Immunology (42 papers). Zahir Amoura collaborates with scholars based in France, United States and Morocco. Zahir Amoura's co-authors include Julien Haroche, Jean‐Charles Piette, Alexis Mathian, Laurent Arnaud, Guy Gorochov, Makoto Miyara, B. Wechsler, N. Costedoat‐Chalumeau, P. Cacoub and Fleur Cohen‐Aubart and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Zahir Amoura

387 papers receiving 17.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor

2009 1.8k citations Makoto Miyara, Christophe Parizot et al. profile →
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

2020 549 citations Zahir Amoura et al. profile →
Human FoxP3+ regulatory T cells in systemic autoimmune diseases

2011 273 citations Makoto Miyara, Guy Gorochov et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zahir Amoura France	75	7.3k	6.3k	4.3k	3.2k	1.8k	424	17.6k
Manuel Ramos‐Casals Spain	70	7.8k 1.1×	4.2k 0.7×	5.7k 1.3×	2.0k 0.6×	2.6k 1.5×	258	18.2k
Xavier Mariette France	73	7.3k 1.0×	4.7k 0.8×	6.2k 1.5×	1.4k 0.4×	1.7k 1.0×	452	19.6k
Jean Sibilia France	70	6.8k 0.9×	4.1k 0.7×	2.1k 0.5×	2.4k 0.8×	2.2k 1.2×	460	16.8k
Jean‐Charles Piette France	69	6.0k 0.8×	2.9k 0.5×	2.0k 0.5×	2.4k 0.8×	1.9k 1.0×	201	14.1k
E. William St. Clair United States	55	9.1k 1.2×	5.3k 0.8×	1.6k 0.4×	3.0k 0.9×	1.2k 0.6×	170	16.5k
Stefano Bombardieri Italy	65	6.4k 0.9×	5.1k 0.8×	3.0k 0.7×	1.5k 0.5×	1.8k 1.0×	448	16.2k
Guido Valesini Italy	64	8.2k 1.1×	4.4k 0.7×	2.2k 0.5×	982 0.3×	1.6k 0.9×	561	16.3k
Eric L. Matteson United States	84	12.4k 1.7×	4.0k 0.6×	4.3k 1.0×	10.3k 3.2×	2.9k 1.6×	465	25.5k
Cees G. M. Kallenberg Netherlands	72	6.6k 0.9×	6.8k 1.1×	3.6k 0.8×	8.0k 2.5×	1.3k 0.7×	369	18.0k
Miguel Á. González‐Gay Spain	81	13.5k 1.8×	6.3k 1.0×	2.0k 0.5×	8.4k 2.6×	2.9k 1.6×	799	25.0k

Countries citing papers authored by Zahir Amoura

Since Specialization

Citations

This map shows the geographic impact of Zahir Amoura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zahir Amoura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zahir Amoura more than expected).

Fields of papers citing papers by Zahir Amoura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zahir Amoura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zahir Amoura. The network helps show where Zahir Amoura may publish in the future.

Co-authorship network of co-authors of Zahir Amoura

This figure shows the co-authorship network connecting the top 25 collaborators of Zahir Amoura. A scholar is included among the top collaborators of Zahir Amoura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zahir Amoura. Zahir Amoura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dorgham, Karim, et al.. (2025). Comment on: Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis. Lara D. Veeken. 64(7). 4436–4437.

Pegoraro, Francesco, Francesco Peyronel, Matthias Papo, et al.. (2025). Risk of Second Cancer in Erdheim-Chester Disease. JAMA Oncology. 11(4). 429–429. 2 indexed citations

Yelnik, Cécile, Ada Clarke, Matthias Papo, et al.. (2025). Vascular liver disorders in patients with antiphospholipid syndrome: a national retrospective multicentre study. Lara D. Veeken. 64(8). 4614–4621.

Papo, Matthias, Pierre Cappy, Paul‐Louis Woerther, et al.. (2024). Lymphadenopathy in systemic lupus erythematosus: no microbial trigger found by shotgun metagenomics in a retrospective study on 38 patients. Lara D. Veeken. 64(6). 3906–3909.

Paredes, D., Guillermo Ruiz‐Irastorza, & Zahir Amoura. (2023). Systemic lupus erythematosus and glucocorticoids: A never-ending story?. Best Practice & Research Clinical Rheumatology. 37(4). 101873–101873. 6 indexed citations

Chasset, François, Alexis Mathian, Noémie Abisror, et al.. (2023). Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus. Journal of the American Academy of Dermatology. 89(1). 171–173. 24 indexed citations

Kernéis, Mathieu, Fleur Cohen, Alain Combes, et al.. (2023). Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis. Archives of cardiovascular diseases. 116(10). 460–466. 25 indexed citations

Riquin, Élise, Elena Freri, Tiziana Granata, et al.. (2020). Psychiatric autoimmune conditions in children and adolescents: Is catatonia a severity marker?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 104. 110028–110028. 12 indexed citations

Chambrun, Marc Pineton de, Catherine Settegrana, Karim Dorgham, et al.. (2020). Systemic chloroquine intoxication: a hint from the peripheral blood smear. American Journal of Hematology. 95(7). 873–875.

10.

Cohen‐Aubart, Fleur, Damien Roos‐Weil, Marine Armand, et al.. (2020). High frequency of clonal hematopoiesis in Erdheim-Chester disease. Blood. 137(4). 485–492. 36 indexed citations

11.

Chambrun, Marc Pineton de, et al.. (2020). SARS-CoV-2 Induces Acute and Refractory Relapse of Systemic Capillary Leak Syndrome (Clarkson's Disease). The American Journal of Medicine. 133(11). e663–e664. 19 indexed citations

12.

Lhote, Raphaël, Philippe Greniér, Julien Haroche, et al.. (2019). Characterization of Interstitial Lung Disease Associated With Anti-Ribonucleoprotein Antibodies. JCR Journal of Clinical Rheumatology. 26(8). 327–333. 9 indexed citations

13.

Haroche, Julien, Jean‐François Emile, Frédéric Charlotte, et al.. (2018). La maladie de Destombes-Rosai-Dorfman : évolution du concept, classification et prise en charge. La Revue de Médecine Interne. 39(8). 635–640. 9 indexed citations

14.

Raffin, Marie, Kumaran Deiva, Anne Lépine, et al.. (2016). Catatonia and Autoimmune Conditions in Children and Adolescents: Should We Consider a Therapeutic Challenge?. Journal of Child and Adolescent Psychopharmacology. 27(2). 167–176. 14 indexed citations

15.

Chambrun, Marc Pineton de, Philippe Charron, Danièle Vauthier‐Brouzes, et al.. (2015). Reversible Severe Eosinophilic Endomyocardial Fibrosis During Pregnancy. Medicine. 94(32). e1307–e1307. 2 indexed citations

16.

Terrier, Benjamin, Ivan Bièche, Thierry Maisonobe, et al.. (2010). Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome. Blood. 116(22). 4523–4531. 99 indexed citations

17.

Cohen‐Bittan, Judith, Jacques Boddaert, G. Guettrot-Imbert, et al.. (2010). Atypical dementia. The Lancet. 376(9741). 656–656. 1 indexed citations

18.

Taflin, Cécile, Makoto Miyara, Dominique Nochy, et al.. (2009). FoxP3+ Regulatory T Cells Suppress Early Stages of Granuloma Formation but Have Little Impact on Sarcoidosis Lesions. American Journal Of Pathology. 174(2). 497–508. 102 indexed citations

19.

Arnaud, Laurent, Julien Haroche, Jean‐Charles Piette, & Zahir Amoura. (2009). Biothérapies des maladies auto-immunes : quelles perspectives ?. 15(2). 75–86. 1 indexed citations

20.

Miyara, Makoto, Zahir Amoura, Christophe Parizot, et al.. (2006). The immune paradox of sarcoidosis and regulatory T cells. The Journal of Experimental Medicine. 203(2). 359–370. 337 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact